CUMYL-THPINACA

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
CUMYL-THPINACA
CUMYL-THPINACA.png
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C23H27N3O2
Molar mass 377.5 g/mol
3D model (JSmol)

CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid.[1] CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors.[2]

Legal status[edit]

Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014.[3]

As of October 2015 CUMYL-THPINACA is a controlled substance in China.[4]

See also[edit]

References[edit]

  1. ^ "CUMYL-THPINACA". Cayman Chemical. Retrieved 11 July 2015. 
  2. ^ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015. 
  3. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015. 
  4. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.